Page last updated: 2024-11-13

aloxiprin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID71586929
MeSH IDM0056680

Synonyms (26)

Synonym
9014-67-9
paloxin
alaprin
aloxiprine [inn-french]
superpyrin
aloxiprina [inn-spanish]
lyman
rumatral
unii-6qt214x4xu
aloxiprin
aloxiprine
aloxiprina
aloxiprinum
oalaprin
aloxiprinum [inn-latin]
palaprin forte
6qt214x4xu ,
aloxiprin [inn:ban:dcf]
aloxiprin [mart.]
aloxiprin [inn]
aloxiprin [who-dd]
aloxiprin [mi]
DTXSID60238044
Q27888708
DB13509
dialuminum;2-acetyloxybenzoic acid;oxygen(2-)

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
"The effect of 7-mono-hydroxyethylrutoside and its combination with acetylsalicylic acid was evaluated in a controlled clinical trial, performed in 105 patients with obliterative atherosclerosis of the lower limbs, and using non-invasive measurement of peripheral haemodynamic parameters--blood flow during reactive hyperaemia and ankle systolic blood pressure."( The effect of hydroxyethylrutoside and its combination with acetylsalicylic acid in patients with obliterative atherosclerosis.
Linhart, J; Oliva, I; Prerovský, I; Roztocil, K, 1989
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.60

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.60 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index42.09 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.60)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (30.77%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (7.69%)4.05%
Observational0 (0.00%)0.25%
Other8 (61.54%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]